VaramirStart free · no cardSign in
NVAX as of Oct 31 · 07:00 ET
NVAXNasdaqBiological Products, (No Diagnostic Substances)

Novavax Inc · Brief

Next report

5 days

Nov 5 · before openconfirmedQ3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
4 of 8≥ implied
avg implied
±11.8%
avg realized
±8.7%
Feb 27 '25±15.7%▼−3.55%×0.23
May 8 '25±13.1%▲+11.93%×0.91
Aug 6 '25±11.4%▲+12.63%×1.11
Q3 FY25±12.8%▼−1.30%×0.10
Jan 12 '26±6.2%▲+6.60%×1.06
Q1 FY26±10.2%▲+17.42%×1.71
May 6 '26±10.2%▲+15.56%×1.53
Q2 FY26±14.5%▲+0.52%×0.04
quarterimplied−20%0+20%realized×
Q2 FY26±14.5%▲+0.52%×0.04
May '26±10.2%▲+15.56%×1.53
Q1 FY26±10.2%▲+17.42%×1.71
Jan '26±6.2%▲+6.60%×1.06
Q3 FY25±12.8%▼−1.30%×0.10
Aug '25±11.4%▲+12.63%×1.11
2 older reports
May '25±13.1%▲+11.93%×0.91
Feb '25±15.7%▼−3.55%×0.23
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · confirmed

Bull2 of 4

15disclosed supplier and customer ties in SEC filingsSEC filings
4tracked funds holding NVAXN-PORT · Aug 31 '26

Bear2 of 4

10 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
19managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

NVAX report session

Customers 1

PFEPfizer×0.09
× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 29report dateEarnings date confirmed: Nov 5, before open.Source
Oct 22impliedImplied move: ±15.2% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.